Undescended Testicle Surgery in India
Get Undescended Testicle Surgery at internationally accredited (JCI/NABH) Indian hospitals at a fraction of Western costs, with end-to-end international patient support — visa, travel, stay, and follow-up care.
Undescended Testicle Surgery in UAE
Undescended Testicle Surgery at leading UAE hospitals in Dubai and Abu Dhabi — world-class care closer to home, visa-free entry for many nationalities, international specialists, and modern facilities.
Overview
Undescended testicle surgery (orchiopexy) is a well-established urological procedure that repositions one or both cryptorchid testes into the scrotal sac, with published success rates exceeding 95% when performed by high-volume pediatric urologists. International families and adult patients travel to India and the UAE through GAF Healthcare to access JCI- and NABH-accredited centers offering robotic-assisted and laparoscopic orchiopexy at costs dramatically lower than Western counterparts, without compromising clinical outcomes. GAF Healthcare provides end-to-end coordination — from specialist matching and visa facilitation to post-operative follow-up — ensuring a seamless, medically supervised journey.
Hospital Stay: 1–3 days (day-surgery for standard cases; 2–3 days for laparoscopic or staged procedures) • Total Stay in Country (Fit-to-Fly): 1–2 weeks (short-haul); 2–3 weeks recommended for long-haul international flights • Success Rate: 95–98%
What Is It?
Cryptorchidism — the failure of one or both testes to descend into the scrotal sac by birth — affects approximately 1–3% of full-term male neonates and up to 30% of premature male infants. In the majority of cases the testis is palpable, lying within the inguinal canal, but in roughly 20% it is non-palpable, situated intra-abdominally or atrophic. Left uncorrected, cryptorchidism carries significant long-term physiological consequences: elevated scrotal temperature impairs spermatogenesis, increasing the lifetime risk of infertility by two- to sixfold; the risk of testicular germ-cell tumour is 3–10 times higher than in the general male population; and associated complications include torsion, inguinal hernia, and psychological impact related to scrotal appearance.
The pathophysiology involves a complex interplay of hormonal (gubernaculum descent mediated by insulin-like factor 3 — INSL3 — and androgen signalling), mechanical (intra-abdominal pressure, gubernacular traction), and genetic factors. Disruption of the hypothalamic–pituitary–gonadal axis during the transabdominal or inguinoscrotal phase of descent leads to malpositioning. Histological studies demonstrate progressive loss of spermatogonial stem cells and Leydig cell dysfunction from as early as 12–18 months of age, which forms the biological rationale for early surgical intervention.
The current international standard of care — endorsed by the European Association of Urology (EAU), the American Urological Association (AUA), and the British Association of Paediatric Urologists (BAPU) — recommends orchiopexy between 6 and 18 months of age for palpable undescended testes, with hormonal therapy (hCG or GnRH analogues) reserved for select cases. For non-palpable testes, diagnostic laparoscopy followed by one- or two-stage Fowler–Stephens orchiopexy is the preferred approach. Adult orchiopexy for late-presenting or recurrent cases is equally well-managed at tertiary centres in India and the UAE, incorporating microsurgical vessel preservation and intra-operative Doppler confirmation.
Candidates
• Infants aged 6–18 months with a confirmed unilateral or bilateral undescended testis (palpable or non-palpable) who have not achieved spontaneous descent by 6 months of corrected gestational age
• Older children or adolescents with late-presenting or previously missed cryptorchidism
• Adult males with untreated or recurrent cryptorchidism, including cases following failed prior orchiopexy
• Patients with an ectopic testis (perineal, femoral, or contralateral scrotal ectopia) confirmed on clinical examination or imaging
• Males with a retractile testis that has become truly ascended (acquired cryptorchidism), verified by serial clinical examination
• Patients with associated inguinal hernia requiring concurrent herniotomy
Required Diagnostics:
• Clinical examination under anaesthesia by a paediatric urologist or andrologist (primary diagnostic tool for palpability assessment)
• High-resolution scrotal and inguinal ultrasound (10–15 MHz probe) to localise palpable testes and assess vascularity; sensitivity ~70% for non-palpable testes
• Diagnostic laparoscopy (gold standard for non-palpable testes; replaces MRI and CT in paediatric guidelines due to superior sensitivity and simultaneous therapeutic capability)
• MRI of the pelvis and inguinal region (optional; used in adolescents and adults when laparoscopy is deferred or for surgical planning in complex re-do cases)
• Hormonal profile: baseline LH, FSH, testosterone, and inhibin B (to assess contralateral testicular function in bilateral cases)
• Karyotype (46,XY confirmation) and AMH/inhibin B levels in bilateral non-palpable cases to exclude anorchia or differences of sex development (DSD)
• Pre-anaesthetic assessment: full blood count, renal and liver function tests, coagulation profile, and paediatric cardiology clearance if congenital cardiac anomalies are suspected
• Sperm analysis / semen cryopreservation counselling for post-pubertal male patients undergoing orchiopexy
Contraindications:
• Confirmed bilateral anorchia (absence of testicular tissue on laparoscopy and hormonal testing) — orchiopexy is not applicable; hormonal replacement therapy is indicated instead
• Active uncontrolled systemic infection or sepsis precluding general anaesthesia
• Uncorrected severe coagulopathy (INR >1.5 unresponsive to correction)
• Testicular atrophy with a volume <1 mL on ultrasound in adults, where orchiectomy rather than orchiopexy may be the appropriate intervention (individualised decision)
• American Society of Anesthesiologists (ASA) Physical Status Class IV–V rendering elective general anaesthesia prohibitively high-risk without optimisation
Procedure
Standard Open Orchiopexy (Inguinal Approach — Gross/Shoemaker Technique): The foundational procedure for palpable inguinal testes. A small inguinal incision allows identification of the spermatic cord, lysis of all fascial attachments (cremaster fibres, gubernaculum), high ligation of a patent processus vaginalis (concurrent herniotomy), and mobilisation of the testis to achieve a tension-free scrotal position. A sub-dartos pouch is created in the hemiscrotum and the testis is fixed using absorbable sutures (Vicryl 4-0 or PDS 4-0) to prevent retraction. Operative time: 45–75 minutes. Requires general anaesthesia with caudal or ilioinguinal nerve block for post-operative analgesia.
Laparoscopic Orchiopexy (Single-Stage — for Intra-abdominal Testes): When the testis is located within 2 cm of the internal inguinal ring with adequate vessel length, a single-stage laparoscopic orchiopexy is performed. A 5 mm umbilical port is placed for a 30-degree telescope; two 3–5 mm working ports are inserted. The testicular vessels and vas deferens are dissected under 10× magnification, peritoneal attachments are released, and the testis is delivered into the scrotum through a neo-hiatus medial to the inferior epigastric vessels (Prentiss manoeuvre). Intra-operative Doppler probe confirms vascular integrity. This approach offers superior visualisation of intra-abdominal anatomy, reduced post-operative pain, and faster return to activity compared to open surgery in experienced hands.
Fowler–Stephens Orchiopexy (Two-Stage — for High Intra-abdominal Testes): Indicated when the testis lies >2 cm above the internal ring with short testicular vessels. Stage 1: Laparoscopic ligation of the testicular artery and vein (while preserving the vasal artery and cremasteric collaterals), performed 6 months prior to Stage 2 to allow collateral vascularisation to develop via the vasal artery and peritoneal vessels. Stage 2: Orchiopexy with a pedicle based on the vasal vessels and peritoneal flap, routed medial to the inferior epigastric vessels into the scrotum. Success rate for two-stage Fowler–Stephens: 85–90% (versus ~97% for single-stage procedures). Testicular atrophy rates post-Fowler–Stephens: 8–15%, decreasing with laparoscopic compared to open technique.
Microsurgical Autotransplantation: Offered at select high-volume centres in India and the UAE for cases where standard orchiopexy would leave the testis under tension or at high atrophy risk. The testicular artery and vein are divided and reanastomosed to the inferior epigastric vessels using an operating microscope (10–25× magnification). Reported testicular survival rates: 90–95%. Requires expertise in microsurgical vascular anastomosis and intra-operative angiography; available at tertiary centres in Mumbai, Chennai, Delhi, Dubai, and Abu Dhabi.
Robotic-Assisted Orchiopexy: DA Vinci Xi or SP (Single Port) robotic platform is increasingly utilised for complex re-do orchiopexy, bilateral cases requiring precise bilateral vessel dissection, or orchiopexy in obese adolescents/adults. Robotic assistance provides 3D HD visualisation, tremor filtration, and 7-degrees-of-freedom instrument articulation — advantages particularly relevant when dissecting near the vas deferens and testicular vessels in a scarred re-operative field. Available at Apollo Hospitals, Fortis, and AIIMS-affiliated centres in India, and at Cleveland Clinic Abu Dhabi and Mediclinic City Hospital in Dubai.
Orchiectomy (for Atrophic or Post-pubertal High Intra-abdominal Testes): In post-pubertal males (>13 years) with an atrophic intra-abdominal testis (volume <2 mL) and normal contralateral testis, orchiectomy is preferred over orchiopexy given the elevated malignancy risk and poor spermatogenic potential. Can be performed laparoscopically as a day-case procedure. Testicular prosthesis implantation is offered simultaneously or at a deferred stage for psychosocial benefit.
Cost of Undescended Testicle Surgery: India vs. UAE
The cost of undescended testicle surgery varies significantly between India and the UAE, primarily reflecting differences in hospital infrastructure pricing, labour costs, and the broader medical tourism ecosystem in each destination — while maintaining equivalent clinical standards at JCI- and NABH/DHA-accredited institutions. India offers the most cost-competitive option globally for orchiopexy, with all-inclusive packages typically running 50–65% below UAE pricing, making it the preferred destination for families seeking premium surgical expertise at accessible cost. The UAE — particularly Dubai and Abu Dhabi — commands a premium reflecting its luxury hospital infrastructure, Western-trained specialist density, and the ease of access for patients from the GCC, Africa, and Europe. Both destinations deliver laparoscopic, robotic, and microsurgical capabilities; cost differences are structural, not clinical.
| Destination | Estimated Cost (USD) | Key Advantage |
|---|---|---|
| India | $1,500 – $4,500 | ~52% less than the UAE |
| UAE (Dubai/Abu Dhabi) | $3,500 – $9,000 | Premium care, JCI/DHA accredited |
Estimates typically include surgery, hospital stay, and standard medications. Contact us for a personalised quote.
Recovery & Aftercare
Pre-Operative Phase (Days –7 to –1):
• Virtual consultation with GAF Healthcare's assigned paediatric urologist or andrologist (video call with medical records review, imaging review, and surgical plan discussion)
• Arrival in India or UAE 5–7 days before surgery for paediatric patients requiring pre-anaesthetic optimisation; 2–3 days for straightforward elective cases
• On-arrival diagnostic workup: clinical examination under sedation (if required), ultrasound, and laboratory panel as indicated
• Anaesthesiology assessment: paediatric patients receive dedicated paediatric anaesthesiologist evaluation; weight-based drug dosing, fasting guidelines (2 hours clear fluids, 4 hours breast milk, 6 hours formula/solid food per current guidelines)
• Patient and family education by the nursing coordinator: wound care, activity restrictions, pain management, and signs of complications
• Consent process conducted with a certified medical interpreter provided by GAF Healthcare if required
Day of Surgery (Day 0):
• Admission 2 hours pre-operatively; IV access, pre-medication (oral midazolam for anxious paediatric patients, or IV induction)
• General anaesthesia induction; supplementary caudal epidural block (0.25% bupivacaine, 1 mL/kg) or ilioinguinal nerve block placed for post-operative analgesia
• Surgical duration: Open orchiopexy: 45–90 minutes; Laparoscopic single-stage: 60–120 minutes; Two-stage Fowler–Stephens (each stage): 90–150 minutes; Robotic-assisted: 90–180 minutes
• Recovery room monitoring: SpO2, HR, blood pressure, and pain scoring (FLACC scale for paediatric patients) for 1–2 hours post-extubation
• Majority of standard unilateral open or laparoscopic cases are managed as day-surgery with discharge the same evening
Post-Operative Days 1–3 (In-Hospital or Hotel Observation):
• Pain management: scheduled paracetamol (15 mg/kg q6h) and ibuprofen (5–10 mg/kg q8h) — avoiding opioids in most paediatric cases; adult patients may receive tramadol or low-dose oxycodone PRN
• Wound check at 24 hours; scrotal support applied; absorbable sutures require no removal
• Oral diet resumed within 4–6 hours of recovery from anaesthesia
• Bilateral or two-stage cases: 2–3 night in-patient stay for monitoring of testicular viability (scrotal colour, swelling, and Doppler assessment at 48 hours)
Post-Operative Week 1–2 (Recovery in Destination Country):
• Outpatient review at Day 5–7: wound inspection, scrotal examination, ultrasound Doppler of testicular vascularity (mandatory for Fowler–Stephens and microsurgical cases)
• Activity restriction: no straddle toys, cycling, or vigorous play for 3–4 weeks; school/desk work resumable at Day 7–10
• Adult patients: no heavy lifting (>5 kg) or strenuous exercise for 4 weeks; return to sedentary work at Day 7–10
• Fit-to-fly assessment at Day 10–14: clinical examination, wound review, and Doppler confirmation of testicular perfusion
Long-Term Recovery Milestones:
• 6-week post-op: full physical activity resumption; testicular position and volume confirmed on clinical examination
• 3-month post-op: follow-up ultrasound to confirm testicular position, growth, and vascularity; GP/paediatrician handover report provided by GAF Healthcare
• Annual follow-up: testicular self-examination education initiated at adolescence; semen analysis offered at 18+ years to assess fertility outcomes
• Stage 2 (if Fowler–Stephens, two-stage): scheduled 6 months after Stage 1, coordinated by GAF Healthcare with the same surgical team
Risks & Considerations
Orchiopexy is among the safest elective urological procedures performed globally, with a complication rate of less than 5% in high-volume centres; however, patients and families should be counselled on the following procedure-specific risks:
Testicular Atrophy: The most clinically significant complication, occurring in 1–2% of standard inguinal orchiopexies and up to 8–15% following two-stage Fowler–Stephens procedures, due to compromise of the testicular artery. Identified on follow-up Doppler ultrasound; atrophic testes are monitored for malignant transformation.
Top Hospitals for Undescended Testicle Surgery
Top Doctors for Undescended Testicle Surgery
Internationally trained specialists in Urology. Review their profiles, compare experience, and connect directly through GAF Healthcare.

Dr. Gaurav Kataria
MCh, MS, MBBS
Urologist
Paras Hospitals, Gurgaon, India
23+ Yearsof experience
Dr. Gaurav Kataria is a Senior Consultant Urologist at Paras Hospitals in Gurgaon with more than 23 years of clinical experience in urological care and genito-urinary surgery. He completed his MCh in Urology from the prestigious Jawaharlal Institute of Post Graduate Medical Education and Research (JIPMER) in 2017, building on a strong foundation of MS in General Surgery (2011) and MBBS (2005). His credentials reflect a commitment to advanced surgical… Read more

Dr. Gutta Srinivas
MBBS, MS, DNB
Urologist & Transplant Surgeon
Yashoda Hospitals, Hi-Tech City, Hyderabad, India
25+ Yearsof experience
Dr. Gutta Srinivas is a Senior Consultant Urologist and Transplant Surgeon serving as Clinical Director of the Department of Urology at Yashoda Hospitals, Hi-Tech City, Hyderabad. With over 25 years of clinical experience, he has established himself as a leading figure in urological surgery and renal transplantation across India. His pioneering work includes performing India's first ABO-incompatible kidney transplant using the Adsorbent Technique—a… Read more

Dr. Jangvir Singh Grewal
MBBS, MS in General Surgery, MCh in Urology and Renal Transplant Program, DrNB in Genitourinary Surgery
Urologist
Medanta - The Medicity, Gurugram, India
3+ Yearsof experience
Dr. Jangvir Singh Grewal is an Associate Consultant in Urology at Medanta - The Medicity, Gurugram, where he brings over three years of clinical experience in managing complex urological and renal conditions. He holds an MCh in Urology and Renal Transplant Program from Madurai Medical College (completed 2023), a DrNB in Genitourinary Surgery, and an MS in General Surgery from Pt. B.D. Sharma PGIMS, UHS Rohtak, providing him with a strong surgical… Read more

Dr. Lokesh Sinha
MBBS, MS, DNB
Urologist
Gleneagles Hospital, Mumbai, India
16+ Yearsof experience
Dr. Lokesh Sinha is a Senior Consultant Urologist at Gleneagles Hospital in Mumbai with over 16 years of clinical excellence in urological surgery. He holds a prestigious academic background with MBBS, MS, and DNB qualifications, and was awarded a Gold Medal in MS for General Surgery, reflecting his exceptional surgical skill and commitment to patient care. His surgical practice spans the full spectrum of modern urology, with particular expertise in… Read more

Dr. M. Gopichand
MBBS, MCh (Urology & Andrology), DNB (Urology)
Urologist
Yashoda Hospitals, Hyderabad, India
26+ Yearsof experience
Dr. M. Gopichand is a Senior Consultant Urologist at Yashoda Hospitals in Hyderabad with over 26 years of distinguished clinical practice in urology. He holds an MCh in Urology & Andrology from Bombay Hospital Institute of Medical Sciences and a DNB in Urology from New Delhi, credentials that underpin his comprehensive expertise across the full spectrum of urological diseases. He is recognized as one of South India's most accomplished urologists,… Read more
Frequently Asked Questions — Undescended Testicle Surgery
In India, orchiopexy at a JCI- or NABH-accredited hospital coordinated through GAF Healthcare typically costs between USD 1,500 and USD 4,500 for a complete package including the surgeon's fee, anaesthesiologist fee, operating theatre charges, 1–3 nights of hospital accommodation, standard medications, and post-operative wound dressing. Laparoscopic or robotic-assisted cases, bilateral procedures, or two-stage Fowler–Stephens orchiopexy for high intra-abdominal testes sit at the higher end of this range. In the UAE (Dubai or Abu Dhabi), the equivalent procedure at a JCI- or DHA-accredited facility costs between USD 3,500 and USD 9,000, with the premium reflecting the UAE's hospital infrastructure pricing, Western-trained specialist fees, and higher operational costs. In both destinations, GAF Healthcare provides a transparent itemised quote before any commitment is made. Optional extras — such as private room upgrades, additional diagnostic imaging, or testicular prosthesis implantation — are quoted separately. Notably, India's pricing is approximately 50–65% lower than the UAE for clinically equivalent surgical outcomes, making India the preferred destination for cost-conscious families, while the UAE suits patients who prioritise proximity (GCC region), luxury infrastructure, or English-/Arabic-speaking care environments.
For straightforward unilateral open or single-stage laparoscopic orchiopexy — the most common scenario — patients are typically cleared for short-haul flights (under 4 hours) by Day 7–10 post-surgery, following a wound check and clinical examination. For long-haul international flights (over 6 hours), GAF Healthcare's surgical teams recommend a minimum 2-week in-country stay to allow adequate wound healing, confirm testicular viability on Doppler ultrasound, and ensure post-anaesthetic recovery is complete in paediatric patients. For two-stage Fowler–Stephens orchiopexy, Stage 1 requires a 1-week stay; Stage 2 (performed 6 months later) similarly requires a 2-week stay. Microsurgical autotransplantation cases, given the vascular anastomosis involved, require a minimum 2–3 week stay before long-haul travel is cleared. GAF Healthcare issues a formal 'Fit-to-Fly' medical certificate — signed by the treating surgeon — at the final pre-departure consultation, which is accepted by most airlines and travel insurers. Families should also note that infants who were premature at birth may require additional anaesthetic recovery time per the treating anaesthesiologist's assessment.
The overall success rate of orchiopexy — defined as the testis achieving and maintaining a stable scrotal position with preserved vascularity on follow-up Doppler ultrasound — is 95–98% for standard open and single-stage laparoscopic orchiopexy performed at high-volume centres. For two-stage Fowler–Stephens orchiopexy (used in high intra-abdominal testes with short vessels), the success rate is 85–90%, with testicular atrophy rates of 8–15% depending on technique and operator experience. Microsurgical autotransplantation achieves testicular survival in approximately 90–95% of cases at specialist centres. 'Clinical success' in orchiopexy encompasses three dimensions: (1) Anatomical success — confirmed scrotal position and testicular size preservation at 6-month and 1-year follow-up ultrasound; (2) Fertility outcomes — evidence from long-term cohort studies shows that early orchiopexy (before 18 months) significantly improves spermatogenic potential compared to late surgery, with paternity rates of 75–90% in unilateral and 50–65% in bilateral cases; (3) Oncological risk reduction — orchiopexy reduces testicular germ-cell tumour risk by approximately 2–6 fold compared to untreated cryptorchidism, though lifelong surveillance remains necessary. All GAF Healthcare partner hospitals provide structured long-term follow-up planning and coordinate with the patient's home-country physician to ensure continuity of surveillance.
Why Plan Your Treatment Through Gaf Healthcare?
GAF Healthcare manages every non-clinical dimension of the medical journey for orchiopexy patients and their families traveling to India or the UAE, ensuring that logistical complexity does not distract from clinical recovery.
Visa & Entry Facilitation: For India: GAF Healthcare's visa team prepares and submits the complete e-Medical Visa (eMV) application package on behalf of the patient and up to two attendants (parent/guardian for paediatric cases). The eMV is typically granted within 72 hours and permits a stay of up to 60 days with triple-entry provision — sufficient for both stages of a two-stage Fowler–Stephens procedure. Invitation letters from the treating hospital, case summaries, and appointment confirmations are provided as part of the documentation package. For UAE (Dubai / Abu Dhabi): Nationals of over 90 countries including the GCC, EU, UK, USA, Canada, and Australia receive visa-on-arrival or visa-free access to the UAE. For nationalities requiring advance visas, GAF Healthcare coordinates medical tourist visas through its registered UAE entity, with typical approval in 3–5 business days. Multi-entry options are arranged for two-stage procedure patients.
Airport-to-Hospital Transfers: Dedicated, air-conditioned vehicle transfers are arranged for arrival, inter-facility transfers (e.g., diagnostic centre to hospital), and departure — with child-appropriate seating (car seats or booster seats) provided for paediatric patients upon request. A GAF Healthcare ground coordinator meets the family at the arrival terminal.
Medical Translation & Interpretation: Certified medical interpreters are available in Arabic, French, Russian, Swahili, Bengali, Dari/Pashto, and other major languages. For paediatric cases, a consistent interpreter is assigned throughout the hospital stay to support informed consent processes, nursing communication, and discharge education.
Accommodation for Attendants: GAF Healthcare partners with serviced apartments and family-friendly hotels within 1–3 km of all partner hospitals, offering discounted rates for attending parents or guardians. Options range from budget-comfortable (from USD 35/night near partner hospitals in Chennai and Hyderabad) to premium serviced residences adjacent to Cleveland Clinic Abu Dhabi or Mediclinic City Hospital Dubai (from USD 120/night). In-room meal delivery, laundry, and 24/7 helpline access are standard across all accommodation tiers.
Post-Discharge Teleconsultation: Following return home, GAF Healthcare facilitates a structured teleconsultation schedule with the treating surgeon at Day 7, Day 30, and 3 months post-surgery. All operative reports, histopathology (if applicable), imaging, and discharge summaries are provided in digitally signed PDF format within 48 hours of discharge for onward sharing with the patient's home-country paediatrician or urologist.
